Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,078
archived clinical trials in
Major Depression Disorder (MDD)

Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder
A Phase 1, Multicenter, Randomized, Double-blind, Sequential Cohort, Placebo-controlled Trial to Assess the Safety and Tolerability of Ascending Multiple Oral Doses of Brexpiprazole as Adjunctive Therapy in the Treatment of Elderly Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  1/5/2016
Miami Jewish Health System
996
mi
from 43215
Miami, FL
Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder
A Phase 1, Multicenter, Randomized, Double-blind, Sequential Cohort, Placebo-controlled Trial to Assess the Safety and Tolerability of Ascending Multiple Oral Doses of Brexpiprazole as Adjunctive Therapy in the Treatment of Elderly Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 1/5/2016
Miami Jewish Health System
996
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder
A Phase 1, Multicenter, Randomized, Double-blind, Sequential Cohort, Placebo-controlled Trial to Assess the Safety and Tolerability of Ascending Multiple Oral Doses of Brexpiprazole as Adjunctive Therapy in the Treatment of Elderly Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  1/5/2016
St. Louis Clinical Trials
396
mi
from 43215
St. Louis, MO
Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder
A Phase 1, Multicenter, Randomized, Double-blind, Sequential Cohort, Placebo-controlled Trial to Assess the Safety and Tolerability of Ascending Multiple Oral Doses of Brexpiprazole as Adjunctive Therapy in the Treatment of Elderly Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 1/5/2016
St. Louis Clinical Trials
396
mi
from 43215
St. Louis, MO
Click here to add this to my saved trials
Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder
A Phase 1, Multicenter, Randomized, Double-blind, Sequential Cohort, Placebo-controlled Trial to Assess the Safety and Tolerability of Ascending Multiple Oral Doses of Brexpiprazole as Adjunctive Therapy in the Treatment of Elderly Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  1/5/2016
CRI Lifetree- Philadelphia Research Center
416
mi
from 43215
Philadelphia, PA
Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder
A Phase 1, Multicenter, Randomized, Double-blind, Sequential Cohort, Placebo-controlled Trial to Assess the Safety and Tolerability of Ascending Multiple Oral Doses of Brexpiprazole as Adjunctive Therapy in the Treatment of Elderly Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 1/5/2016
CRI Lifetree- Philadelphia Research Center
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
A Study to Investigate Evoked Potentials as Markers of Ketamine-induced Cortical Plasticity in Patients With Major Depressive Disorder
An Open-Label and Double-Blind Study to Investigate Evoked Potentials as Markers of Ketamine-induced Cortical Plasticity in Subjects With Major Depressive Disorder
Status: Enrolling
Updated:  1/7/2016
Clinical Research Facility
354
mi
from 43215
Durham, NC
A Study to Investigate Evoked Potentials as Markers of Ketamine-induced Cortical Plasticity in Patients With Major Depressive Disorder
An Open-Label and Double-Blind Study to Investigate Evoked Potentials as Markers of Ketamine-induced Cortical Plasticity in Subjects With Major Depressive Disorder
Status: Enrolling
Updated: 1/7/2016
Clinical Research Facility
354
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD.
Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD.
Status: Enrolling
Updated:  1/7/2016
Western Psychiatric Institute and Clinic
165
mi
from 43215
Pittsburgh, PA
Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD.
Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD.
Status: Enrolling
Updated: 1/7/2016
Western Psychiatric Institute and Clinic
165
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Psychosis: Early Detection, Intervention and Prevention
Psychosis: Early Detection, Intervention and Prevention
Status: Enrolling
Updated:  1/7/2016
Maine Medical Center
704
mi
from 43215
Portland, ME
Psychosis: Early Detection, Intervention and Prevention
Psychosis: Early Detection, Intervention and Prevention
Status: Enrolling
Updated: 1/7/2016
Maine Medical Center
704
mi
from 43215
Portland, ME
Click here to add this to my saved trials
Effectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major Depression
Effectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major Depression
Status: Enrolling
Updated:  1/12/2016
Massachusetts Correctional Institution - Framingham
624
mi
from 43215
Framingham, MA
Effectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major Depression
Effectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major Depression
Status: Enrolling
Updated: 1/12/2016
Massachusetts Correctional Institution - Framingham
624
mi
from 43215
Framingham, MA
Click here to add this to my saved trials
Effectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major Depression
Effectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major Depression
Status: Enrolling
Updated:  1/12/2016
South Middlesex Correctional Center
624
mi
from 43215
Framingham, MA
Effectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major Depression
Effectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major Depression
Status: Enrolling
Updated: 1/12/2016
South Middlesex Correctional Center
624
mi
from 43215
Framingham, MA
Click here to add this to my saved trials
Effectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major Depression
Effectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major Depression
Status: Enrolling
Updated:  1/12/2016
Massachusetts Correctional Institution - Norfolk
627
mi
from 43215
Norfolk, MA
Effectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major Depression
Effectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major Depression
Status: Enrolling
Updated: 1/12/2016
Massachusetts Correctional Institution - Norfolk
627
mi
from 43215
Norfolk, MA
Click here to add this to my saved trials
Effectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major Depression
Effectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major Depression
Status: Enrolling
Updated:  1/12/2016
Adult Correctional Institution - Men's & Women's Medium & Minimum Security Facilities
617
mi
from 43215
Cranston, RI
Effectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major Depression
Effectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major Depression
Status: Enrolling
Updated: 1/12/2016
Adult Correctional Institution - Men's & Women's Medium & Minimum Security Facilities
617
mi
from 43215
Cranston, RI
Click here to add this to my saved trials
Effectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major Depression
Effectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major Depression
Status: Enrolling
Updated:  1/12/2016
Massachusetts Correctional Institute - Old Colony Correctional Center
643
mi
from 43215
Bridgewater, MA
Effectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major Depression
Effectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major Depression
Status: Enrolling
Updated: 1/12/2016
Massachusetts Correctional Institute - Old Colony Correctional Center
643
mi
from 43215
Bridgewater, MA
Click here to add this to my saved trials
Group Interpersonal Psychotherapy for Treatment of Major Depressive Disorder Following Perinatal Loss
Group Interpersonal Psychotherapy for Treatment of Major Depressive Disorder Following Perinatal Loss
Status: Enrolling
Updated:  1/12/2016
Brown University
619
mi
from 43215
Providence, RI
Group Interpersonal Psychotherapy for Treatment of Major Depressive Disorder Following Perinatal Loss
Group Interpersonal Psychotherapy for Treatment of Major Depressive Disorder Following Perinatal Loss
Status: Enrolling
Updated: 1/12/2016
Brown University
619
mi
from 43215
Providence, RI
Click here to add this to my saved trials
Nitrous Oxide as Treatment for Major Depression - a Pilot Study
Nitrous Oxide as Treatment for Major Depression - a Pilot Study
Status: Enrolling
Updated:  1/13/2016
Barnes Jewish Hospital
397
mi
from 43215
St. Louis, MO
Nitrous Oxide as Treatment for Major Depression - a Pilot Study
Nitrous Oxide as Treatment for Major Depression - a Pilot Study
Status: Enrolling
Updated: 1/13/2016
Barnes Jewish Hospital
397
mi
from 43215
St. Louis, MO
Click here to add this to my saved trials
Brexpiprazole (OPC 34712) Trial in the Treatment of Adults With Major Depressive Disorder and Irritability
Protocol 331-13-004: An Exploratory, Multicenter, Single-blind, fMRI Study of Fixed-dose Brexpiprazole (OPC 34712) (2 mg/Day Tablets) as an Adjunctive Treatment
Status: Enrolling
Updated:  1/14/2016
Emory University
435
mi
from 43215
Atlanta, GA
Brexpiprazole (OPC 34712) Trial in the Treatment of Adults With Major Depressive Disorder and Irritability
Protocol 331-13-004: An Exploratory, Multicenter, Single-blind, fMRI Study of Fixed-dose Brexpiprazole (OPC 34712) (2 mg/Day Tablets) as an Adjunctive Treatment
Status: Enrolling
Updated: 1/14/2016
Emory University
435
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Pharmacotherapy in Depression With Panic Spectrum
Pharmacotherapy in Depression With Panic Spectrum
Status: Enrolling
Updated:  1/14/2016
Western Psychiatric Insititue and Clinic
163
mi
from 43215
Pittsburgh, PA
Pharmacotherapy in Depression With Panic Spectrum
Pharmacotherapy in Depression With Panic Spectrum
Status: Enrolling
Updated: 1/14/2016
Western Psychiatric Insititue and Clinic
163
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Study of Repetitive Transcranial Magnetic Stimulation (rTMS) in Depressed Teens
An Open-Label Eight-Week Trial of Repetitive Transcranial Magnetic Stimulation in Depressed Adolescents: Mechanisms of Response
Status: Enrolling
Updated:  1/20/2016
Mayo Clinic Rochester
559
mi
from 43215
Rochester, MN
Study of Repetitive Transcranial Magnetic Stimulation (rTMS) in Depressed Teens
An Open-Label Eight-Week Trial of Repetitive Transcranial Magnetic Stimulation in Depressed Adolescents: Mechanisms of Response
Status: Enrolling
Updated: 1/20/2016
Mayo Clinic Rochester
559
mi
from 43215
Rochester, MN
Click here to add this to my saved trials
Pilot Study to Evaluate Individualized Choice of Antidepressants in Patients With Cancer
A Pilot Study to Evaluate Individualized Choice of Antidepressant in Patients With Cancer
Status: Enrolling
Updated:  1/20/2016
University of North Carolina Hospital
344
mi
from 43215
Chapel Hill, NC
Pilot Study to Evaluate Individualized Choice of Antidepressants in Patients With Cancer
A Pilot Study to Evaluate Individualized Choice of Antidepressant in Patients With Cancer
Status: Enrolling
Updated: 1/20/2016
University of North Carolina Hospital
344
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
Harmonex Neuroscience Research
616
mi
from 43215
Dothan, AL
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
Harmonex Neuroscience Research
616
mi
from 43215
Dothan, AL
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
Dedicated Clinical Research
1678
mi
from 43215
Goodyear, AZ
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
Dedicated Clinical Research
1678
mi
from 43215
Goodyear, AZ
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
University of Arizona Clinical and Translational Science Center (CATS)
1641
mi
from 43215
Tucson, AZ
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
University of Arizona Clinical and Translational Science Center (CATS)
1641
mi
from 43215
Tucson, AZ
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
University of Arizona College of Medicine Dept of Psychiatry
1639
mi
from 43215
Tucson, AZ
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
University of Arizona College of Medicine Dept of Psychiatry
1639
mi
from 43215
Tucson, AZ
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
Arkansas Psychiatric Clinic Clinical Research Trials, P.A.
622
mi
from 43215
Little Rock, AR
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
Arkansas Psychiatric Clinic Clinical Research Trials, P.A.
622
mi
from 43215
Little Rock, AR
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
ATP Clinical Research, Incorporated
1964
mi
from 43215
Costa Mesa, CA
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
ATP Clinical Research, Incorporated
1964
mi
from 43215
Costa Mesa, CA
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
Behavioral Research Specialists, LLC
1970
mi
from 43215
Glendale, CA
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
Behavioral Research Specialists, LLC
1970
mi
from 43215
Glendale, CA
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
Synergy Clinical Research Center
1949
mi
from 43215
National City, CA
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
Synergy Clinical Research Center
1949
mi
from 43215
National City, CA
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
Neuropsychiatric Research Center for Orange County
1959
mi
from 43215
Orange, CA
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
Neuropsychiatric Research Center for Orange County
1959
mi
from 43215
Orange, CA
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
Pacific Clinical Research Medical Group
1959
mi
from 43215
Orange, CA
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
Pacific Clinical Research Medical Group
1959
mi
from 43215
Orange, CA
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
Elite Clinical Trials, Incorporated
1932
mi
from 43215
Wildomar, CA
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
Elite Clinical Trials, Incorporated
1932
mi
from 43215
Wildomar, CA
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
Children's Hospital Colorado
1153
mi
from 43215
Aurora, CO
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
Children's Hospital Colorado
1153
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
Amedica Research Institute, Incorporated
989
mi
from 43215
Hialeah, FL
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
Amedica Research Institute, Incorporated
989
mi
from 43215
Hialeah, FL
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
Kolin Research Group
791
mi
from 43215
Winter Park, FL
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
Kolin Research Group
791
mi
from 43215
Winter Park, FL
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
Atlanta Center for Medical Research
434
mi
from 43215
Atlanta, GA
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
Atlanta Center for Medical Research
434
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
Atlanta Center for Medical Research
434
mi
from 43215
Atlanta, GA
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
Atlanta Center for Medical Research
434
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
Atlanta Center for Medical Research
434
mi
from 43215
Atlanta, GA
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
Atlanta Center for Medical Research
434
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
Institute for Behavioral Medicine
428
mi
from 43215
Smyrna, GA
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
Institute for Behavioral Medicine
428
mi
from 43215
Smyrna, GA
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
Psychiatric Associates
623
mi
from 43215
Overland Park, KA
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
Psychiatric Associates
623
mi
from 43215
Overland Park, KA
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
Lake Charles Clinical Trials LLC
884
mi
from 43215
Lake Charles, LA
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
Lake Charles Clinical Trials LLC
884
mi
from 43215
Lake Charles, LA
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
Precise Research Centers
669
mi
from 43215
Flowood, MS
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
Precise Research Centers
669
mi
from 43215
Flowood, MS
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
Biomedical Systems, Incorporated
406
mi
from 43215
Saint Louis, MO
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
Biomedical Systems, Incorporated
406
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
St Charles Psychiatric Associates - Midwest Research Group
406
mi
from 43215
St. Charles, MO
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
St Charles Psychiatric Associates - Midwest Research Group
406
mi
from 43215
St. Charles, MO
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
Biomedical Systems, Inc
406
mi
from 43215
St. Louis, MO
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
Biomedical Systems, Inc
406
mi
from 43215
St. Louis, MO
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
Biomedical Systems, Inc
406
mi
from 43215
St. Louis, MO
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
Biomedical Systems, Inc
406
mi
from 43215
St. Louis, MO
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
Center for Psychiatry and Behavioral Medicine, Incorporated
1756
mi
from 43215
Las Vegas, NV
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
Center for Psychiatry and Behavioral Medicine, Incorporated
1756
mi
from 43215
Las Vegas, NV
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
North Star Medical Research, LLC
117
mi
from 43215
Middleburg Heights, OH
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
North Star Medical Research, LLC
117
mi
from 43215
Middleburg Heights, OH
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
IPS Research Company
849
mi
from 43215
Oklahoma City, OK
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
IPS Research Company
849
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
Summit Research Network (Oregon), Incorporated
2026
mi
from 43215
Portland, OR
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
Summit Research Network (Oregon), Incorporated
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
Focus and Balance, LLC
1138
mi
from 43215
San Antonio, TX
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
Focus and Balance, LLC
1138
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
Grayline Clinical Drug Trials
952
mi
from 43215
Witchita Falls, TX
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
Grayline Clinical Drug Trials
952
mi
from 43215
Witchita Falls, TX
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
Northwest Clinical Research Center
1998
mi
from 43215
Bellevue, WA
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
Northwest Clinical Research Center
1998
mi
from 43215
Bellevue, WA
Click here to add this to my saved trials
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated:  1/25/2016
Summit Research Network (Seattle) LLC
2006
mi
from 43215
Seattle, WA
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Status: Enrolling
Updated: 1/25/2016
Summit Research Network (Seattle) LLC
2006
mi
from 43215
Seattle, WA
Click here to add this to my saved trials